techwiki
Brusselsllms.txt

Jean-Christophe Tellier

Jean-Christophe Tellier joined UCB in 2011 and became Chief Executive Officer on 1 January 2015, leading the company's transition into a focused biopharmaceutical group with a portfolio centered on neurology and immunology. The UCB Board has proposed renewing his mandate as CEO and director for a further four-year term through 2030. Earlier in his career he held senior roles in the global pharmaceutical industry, including at Novartis and Bristol-Myers Squibb.

Career

Roles
  • UCB#73factoryCEOJan 2015 – Present
  • UCB#73factoryCEO ElectMar 2014 – Dec 2014
  • UCB#73factoryExecutive VP Biopharma Brands and SolutionsFeb 2013 – Feb 2014
  • UCB#73factoryExecutive VP, President of European OperationsJun 2011 – Jan 2013
  • IpsenPresident and General Manager North AmericaMay 2009 – May 2011
  • MacrogenicsExecutive Vice President; Chief Commercial OfficerMay 2008 – Apr 2009
  • Novartis#544factoryCEO Novartis FranceJan 2007 – May 2008
  • Novartis#544factoryGlobal Head Arthitis and bone franchiseSep 2006 – Jan 2007
  • Novartis Pharma AG HQ Switzerlandglobal franchise head2006 – 2007
  • Novartis#544factoryCEO Novartis BelgiumJan 2003 – Aug 2006
  • Novartis#544factoryCOO FranceOct 1999 – Jan 2003
Education

From public career histories · 12 entries

Recent mentions5